Opening book details…
About this Economics, Econometrics and Finance article
Cost-Effectiveness of Daclizumab Versus Interferon Beta-1A in the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in the United States by Rao, D; Heidari, E; Kamal, KM; Dashputre, AA is a Economics, Econometrics and Finance article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Economics, Econometrics and Finance.
- Author
- Rao, D; Heidari, E; Kamal, KM; Dashputre, AA
- Publisher
- John Wiley and Sons; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1098-3015)
- Published
- 2018
- Language
- EN
- Field
- Economics, Econometrics and Finance (Social Sciences)
More by Rao, D; Heidari, E; Kamal, KM; Dashputre, AA
Browse all works by Rao, D; Heidari, E; Kamal, KM; Dashputre, AA